347 related articles for article (PubMed ID: 23816301)
1. Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice.
Hu X; Liu R; Zhu N
Immunobiology; 2013 Dec; 218(12):1524-8. PubMed ID: 23816301
[TBL] [Abstract][Full Text] [Related]
2. Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines.
Chen C; Zhang C; Li R; Wang Z; Yuan Y; Li H; Fu Z; Zhou M; Zhao L
Viruses; 2019 Dec; 11(12):. PubMed ID: 31816996
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
[TBL] [Abstract][Full Text] [Related]
4. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
[TBL] [Abstract][Full Text] [Related]
5. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
6. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
Kaur M; Saxena A; Rai A; Bhatnagar R
FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
Moon SH; Shin EC; Noh YW; Lim YT
Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
[TBL] [Abstract][Full Text] [Related]
9. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice.
Su X; Pei Z; Hu S
Int Immunopharmacol; 2014 Jun; 20(2):283-9. PubMed ID: 24680943
[TBL] [Abstract][Full Text] [Related]
12. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
Luo J; Zhang B; Wu Y; Tian Q; Zhao J; Lyu Z; Zhang Q; Mei M; Luo Y; Guo X
Vaccine; 2017 Feb; 35(6):938-944. PubMed ID: 28089546
[TBL] [Abstract][Full Text] [Related]
14. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble
Margaroni M; Agallou M; Athanasiou E; Kammona O; Kiparissides C; Gaitanaki C; Karagouni E
Int J Nanomedicine; 2017; 12():6169-6184. PubMed ID: 28883727
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.
Li Y; Zhou M; Luo Z; Zhang Y; Cui M; Chen H; Fu ZF; Zhao L
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100620
[TBL] [Abstract][Full Text] [Related]
17. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
Even MP; Young K; Winter G; Hook S; Engert J
Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic vaccination with adjuvant monophosphoryl lipid a prevents Th2-mediated murine asthmatic responses.
Wu CJ; Chou HW; Liou CJ; Shen JJ; Wang LC; Kuo ML
J Asthma; 2013 May; 50(4):327-33. PubMed ID: 23343407
[TBL] [Abstract][Full Text] [Related]
19. Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.
Heeke DS; Lin R; Rao E; Woo JC; McCarthy MP; Marshall JD
Vaccine; 2016 May; 34(23):2562-9. PubMed ID: 27085175
[TBL] [Abstract][Full Text] [Related]
20. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
